CGMP Validation & CQV Services for Pharmaceutical, 503B & CGT Facilities
Restore Health Consulting delivers inspection-ready CGMP validation and CQV services for regulated life sciences facilities operating under FDA oversight.
We help 503B outsourcing facilities, pharmaceutical manufacturers, and cell & gene therapy labs build defensible, risk-based validation programs designed to withstand regulatory scrutiny without unnecessary validation burden or cost.
From facility build-out to requalification and remediation, our team delivers right-sized CQV programs designed to support long-term compliance and operational efficiency.
What Are CGMP Validation & CQV Services?
CGMP validation services refer to the documented processes used to demonstrate that pharmaceutical manufacturing facilities, equipment, utilities, and systems consistently operate according to Current Good Manufacturing Practice (cGMP) regulations established by the FDA and other regulatory authorities.
Commissioning, Qualification, and Validation (CQV) is the structured, lifecycle-based approach used to implement and document cGMP validation. CQV confirms that equipment, utilities, facilities, and computerized systems are properly installed, function as intended, and perform reliably under real-world operating conditions.
Together, CGMP validation and CQV services provide the documented evidence required to demonstrate regulatory compliance, support FDA inspections, and promote reliable pharmaceutical manufacturing operations.
CGMP Validation Services
We provide cost-effective CGMP commissioning and qualification services for 503B, Cell & Gene, and traditional pharmaceutical manufacturing facilities. Our engineers have deep expertise in developing and implementing validation protocols (IQ, OQ, PQ), as well as preparing compliance documentation for equipment, utilities, processes, lab instruments, and computerized systems.
Commissioning, Qualification, Validation
Equipment | Utilities | Lab Instruments | Computer Systems
Refrigerators, Freezers, Incubators, Stability Chambers
Depyrogenation Ovens
Autoclaves
Blenders, Mixers, Agitators
Tablet Presses & Encapsulators
PECs (e.g., LAFW, BSC, RABS, Isolators, Powder Hoods)
Filtration Systems
Glassware, Parts Washers
Aseptic Processing Equipment
Capping Equipment
Inspection Systems
Label & Packaging Equipment
Water Systems (e.g., Water Chillers, PW, WFI)
Compressed Air & Gas Systems
HVAC Systems
Clean-In-Place Systems
Steam/Sterilize-In-Place Systems
Environmental Baseline Studies (EMPQ)
GC & HPLC Instruments
Weighing and Dispensing Systems
Laboratory Information Management Systems
Computer Systems
And More
Our CQV services support your facilities and products in meeting stringent regulatory standards. We provide expert strategies and fractional leadership tailored to your operational and compliance needs.
Risk-Based, Inspection-Defensible CQV Strategy
We support facilities with risk-based, inspection-defensible CQV strategies that align with FDA and state expectations while avoiding unnecessary validation burden.
Our approach integrates facility design, equipment qualification, process risk, and lifecycle management—not just protocol execution.
At Restore Health Consulting, we understand that more testing does not mean lower regulatory risk. CQV strategy shouldn’t be about doing more validation but about approaching validation strategically.
Fractional CQV Leadership
Not every facility needs a full-time validation executive. Our fractional CQV leadership provides senior-level expertise on a flexible basis, helping 503B and CGT facilities design, implement, and maintain inspection-ready validation programs aligned with FDA and cGMP requirements.
Benefits of fractional CQV leadership include:
Reduced full-time overhead
Cost control
Operational confidence and regulatory readiness
Support for build-outs, expansions, remediation, and ongoing oversight
Integration with your quality, engineering, and operations teams
For CGT teams looking to structure their operations and ensure regulatory readiness, fractional CQV leadership or a tailored CQV program can provide both compliance and operational confidence—bringing senior-level expertise while potentially reducing total CQV cost over time.
For 503B outsourcing facilities, engaging third-party consultants on an as-needed basis can be a strategic decision that supports effective and efficient validation processes and flexibility.
FDA Inspection Readiness & Remediation
Prepare for FDA inspections with confidence. Our team identifies gaps, supports remediation efforts, and helps ensure your documentation and validation programs are inspection-ready.
FDA inspections place your validation program, documentation, and quality systems under close scrutiny. We help pharmaceutical, 503B outsourcing, and cell and gene therapy facilities prepare for inspection with CQV programs that are complete, defensible, and aligned with current regulatory expectations.
Our consultants assess existing validation documentation, identify gaps, and implement practical remediation strategies to strengthen compliance without unnecessary revalidation. We focus on helping ensure your equipment qualification, utilities, computerized systems, and validation lifecycle documentation can withstand regulatory review.
Whether preparing for an upcoming FDA inspection or addressing observations from a prior inspection, we provide experienced support to restore compliance, reduce regulatory risk, and help your team move forward with confidence.
Our cGMP and CQV Team
Our team of experienced consultants includes industry experts in GMP pharmaceutical manufacturing, CQV, 503B compounding, and cell & gene therapy. Our consultants are experienced in helping to implement and maintain processes that require a variety of industry guidelines and regulations, with clarity and confidence.
We match clients with the right expertise for:
Senior-level leadership
Advisory support without full-time overhead
Flexible engagement for project-specific needs
Confidential consultation. No obligation.
How Clients Use Us
CQV strategy & scoping before validation begins
Fractional CQV leadership during build-out, expansion, or routine requalification periods
Design, execution and report writing of CQV programs
FDA inspection preparation and remediation
Who We Support
Pharmaceutical and Biotech Companies
We implement science-based CQV processes for new equipment, product launches, or scaling operations—ensuring a compliant, defensible foundation.
503B Outsourcing Facilities
We help facilities maintain GMP compliance, optimize validation scope, and build inspection-defensible CQV programs based on formal risk assessments.
The result is validation that is easier to defend during FDA inspection, easier to maintain over time, and less costly because scope is right sized up front.
Cell & Gene Therapy Labs
Cell and gene therapy (CGT) products face unique challenges compared to traditional biopharmaceuticals. We design and execute tailored CQV strategies that meet cGMP and evolving CGT regulatory frameworks, including fractional leadership for early-stage or high-turnover teams.
Why Restore Health Consulting?
✔ Risk-based validation—not over-validation
✔ Senior-level CQV leadership without full-time overhead
✔ Deep 503B and CGT regulatory experience
✔ Inspection-defensible documentation frameworks
✔ Integration of facility design, operations, and lifecycle management
✔ Experience supporting high-growth 503B and CGT operations in regulated environments
Schedule a CQV Strategy Discussion
Every facility has unique regulatory, operational, and validation challenges. During a focused CQV strategy discussion, we review:
Facility type (503B, pharmaceutical, or cell & gene therapy)
Current CQV scope and documentation status
Upcoming inspections, expansions, or equipment implementation
Gaps in validation leadership or internal resources
You’ll leave with greater clarity on next steps, risk priorities, and how a structured, inspection-defensible CQV approach can support your operational goals.
Confidential consultation. No obligation.
Frequently Asked Questions
What is the difference between commissioning and qualification?
Commissioning verifies installation according to design, while qualification formally documents that systems meet regulatory requirements under cGMP.
What is the CQV process?
CQV (Commissioning, Qualification, Validation) is a lifecycle approach used to demonstrate that facilities, equipment, and systems are installed appropriately, operate as intended, and perform consistently. Key steps include Commissioning, URS, DQ, FAT/SAT, IQ, OQ, PQ, and Validation.
What are the stages of CPV?
Continued Process Verification (CPV) monitors processes after validation to support ongoing control. It includes tracking critical parameters, reviewing trends, investigating deviations, and performing regular process assessments.
How long does a CQV program take?
Timelines depend on facility scope, risk classification, and regulatory requirements. Contact us to discuss what to expect for your business.
Does FDA require risk-based validation?
FDA guidance strongly supports science- and risk-based approaches to validation under cGMP principles, prioritizing efforts based on product safety, quality impact, and process criticality rather than one-size-fits-all testing.
When should a 503B facility begin CQV planning?
Ideally during facility design to avoid costly rework and documentation gaps. This is not a final step but rather a foundational element that must be integrated into the facility buildout and equipment selection to ensure cGMP compliance from day one.